EBITDA for the period rose by 23.2% to Rs. 3,797 million
EBITDA before special items decreases to €4.08 billion (7.4%)
The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
Subscribe To Our Newsletter & Stay Updated